A股異動 | 富臨精工(300432.SZ)漲7% 擬3.33億購買恆信融9%股權
格隆匯9月13日丨富臨精工(300432.SZ)高開逾14%後持續走低,現報44.15元,漲幅縮窄至7.5%,最新總市值328.2億。公司13日公吿稱,擬3.33億購買恆信融9%股權,並以增資的方式再獲其25%股權。恆信融擁有青海省海西州大柴旦行委西台吉乃爾湖東北深層滷水鹽湖資源探礦權,礦區面積為394.26平方公里,礦區位於青海省柴達木盆地中部,為硫酸鎂亞型鹽湖,屬於液體特大型鋰礦牀。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.